RE:RE:RE:Are we dead yet?Hey Jesse,
I don't have much more. I understand the IRB approval is expected this month so it could be any day now. What I do know is that this part of the process is out of the company's hands so it is easy to become very frustrated.
It is true the company is running on fumes and needs a capital injection which I think will happen as soon as the IRB is approved and the clinical trial starts. Depending on the outcome of the clinical trial (not the full outcome but the results from the first 2-3 patients) they company coudl be in a very different situation with the proof of concept in hand on human subjects. There would be a lot more interest in the technology.
Best bet is to stay tuned and follow the story unfold.
~S
PS. This board has become very difficult to navigate with a lot of impossible to follow posts. It's become way more usable just by blocking a couple of users.